Hardman, C., Chen, W., Luo, J., Batty, P., Chen, Y., Nahler, J., . . . Ogg, G. (2019). Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function. Elsevier.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रHardman, C., et al. Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Inhibits Human Group 2 Innate Lymphoid Cell Aggregation and Function. Elsevier, 2019.
एमएलए (9वां संस्करण) प्रशस्ति पत्रHardman, C., et al. Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Inhibits Human Group 2 Innate Lymphoid Cell Aggregation and Function. Elsevier, 2019.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.